Loading...
XFRA27A
Market cap1.45bUSD
, Last price  
0.00EUR
Name

Alpek SAB de CV

Chart & Performance

D1W1MN
XFRA:27A chart
P/E
—
P/S
—
EPS
—
Div Yield, %
%
Shrs. gr., 5y
-0.10%
Rev. gr., 5y
0.53%
Revenues
138.16b
-34.96%
53,573,000,00061,148,000,00090,667,000,00096,163,456,00090,061,169,00086,072,058,00083,590,460,00090,192,000,00098,998,000,000134,523,000,000119,685,000,000113,989,000,000156,224,000,000212,435,000,000138,159,000,000
Net income
-10.91b
L
1,537,000,0002,561,000,0004,290,000,0003,662,549,000261,785,000800,901,0002,748,400,0003,625,000,000-5,487,000,00013,633,000,0006,605,000,0003,123,000,0007,756,000,00013,744,000,000-10,914,000,000
CFO
15.02b
-1.22%
5,600,000,0003,743,000,0004,704,000,0005,483,404,0005,541,831,0006,592,988,0008,178,276,0006,019,000,0007,225,000,0008,261,000,00010,001,000,00011,934,000,00013,230,000,00015,210,000,00015,024,000,000
Earnings
Feb 18, 2025

Profile

Alpek, S.A.B. de C.V., together with its subsidiaries, operates as a petrochemical company in Mexico, the United States, Canada, the United Kingdom, Argentina, Brazil, and Chile. It operates in two segments, Polyester, and Plastics and Chemicals. The Polyester segment produces purified terephthalic acid for use as a raw material in polyethylene terephthalate (PET) and polyester fibers; PET, a plastic resin for use in the beverage bottles, food containers, and consumer good packaging applications; and recycled PET for use in new bottles and containers, strapping and packing supplies, and fibers for clothing and carpet. This segment also offers polyester fibers, such as staple fiber for use in carpets, garments, and home furnishings; and filament for clothing, automotive interiors, and seatbelts, as well as canvases, conveyor belts, hoses, and other industrial uses. The Plastics and Chemicals segment manufactures polypropylene, expandable polystyrene, caprolactam, and other chemicals, as well as specialty and industrial chemicals for use in the consumer goods, food and beverage packaging, automotive, construction, agriculture, oil, and pharmaceutical industries. The company was founded in 1975 and is based in San Pedro Garza García, Mexico. Alpek, S.A.B. de C.V. is a subsidiary of Alfa, S. A. B. de C. V.
URL
https://www.alpek.com/
IPO date
Apr 26, 2012
Employees
7,215
Domiciled in
MX
Incorporated in
MX

Valuation

Title
MXN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
138,159,000
-34.96%
212,435,000
35.98%
156,224,000
37.05%
Cost of revenue
133,805,000
188,438,000
137,668,000
Unusual Expense (Income)
NOPBT
4,354,000
23,997,000
18,556,000
NOPBT Margin
3.15%
11.30%
11.88%
Operating Taxes
727,000
5,509,000
4,115,000
Tax Rate
16.70%
22.96%
22.18%
NOPAT
3,627,000
18,488,000
14,441,000
Net income
(10,914,000)
-179.41%
13,744,000
77.20%
7,756,000
148.35%
Dividends
(2,966,000)
(7,443,000)
(3,710,000)
Dividend yield
11.10%
12.36%
7.89%
Proceeds from repurchase of equity
(10,000)
(66,000)
(56,000)
BB yield
0.04%
0.11%
0.12%
Debt
Debt current
1,390,000
8,533,000
3,393,000
Long-term debt
38,859,000
37,796,000
35,816,000
Deferred revenue
128,000
196,000
Other long-term liabilities
4,148,000
2,538,000
2,161,000
Net debt
32,597,000
30,848,000
14,583,000
Cash flow
Cash from operating activities
15,024,000
15,210,000
13,230,000
CAPEX
(2,501,000)
(3,079,000)
(4,436,000)
Cash from investing activities
(3,320,000)
(12,908,000)
(3,860,000)
Cash from financing activities
(8,532,000)
(5,615,000)
(8,986,000)
FCF
39,575,000
(13,534,000)
9,303,000
Balance
Cash
7,391,000
6,319,000
10,541,000
Long term investments
261,000
9,162,000
14,085,000
Excess cash
744,050
4,859,250
16,814,800
Stockholders' equity
31,381,000
43,277,000
40,610,000
Invested Capital
73,418,950
90,718,750
69,099,200
ROIC
4.42%
23.14%
21.83%
ROCE
5.87%
24.14%
20.61%
EV
Common stock shares outstanding
2,107,000
2,113,000
2,111,000
Price
12.68
-55.51%
28.50
27.92%
22.28
27.90%
Market cap
26,716,760
-55.64%
60,220,500
28.04%
47,033,082
27.78%
EV
67,377,760
96,359,500
67,486,082
EBITDA
8,973,000
28,636,000
22,836,000
EV/EBITDA
7.51
3.36
2.96
Interest
2,402,000
2,036,000
2,607,000
Interest/NOPBT
55.17%
8.48%
14.05%